Isabelle Zelek-Cojean
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Survival modelling of relapse-free survival and competing-risk analysis in patients with high-risk localized prostate cancer treated in GETUG-12.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 07, 2026
ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 07, 2025
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2025
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.
Journal: Nature communications
Published: March 07, 2025
Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
Journal: Clinical genitourinary cancer
Published: March 14, 2023
A Case of Heavily Pretreated Metastatic Germ Cell Tumor With Ongoing Long-term Complete Response After Gemcitabine Treatment.
Journal: Clinical genitourinary cancer
Published: November 29, 2018
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study.
Journal: British journal of cancer
Published: September 30, 2018
Physicians' Attitudes Towards the Advice of a Guideline-Based Decision Support System: A Case Study With OncoDoc2 in the Management of Breast Cancer Patients.
Journal: Studies in health technology and informatics
Published: August 12, 2015
Dose intensity and toxicity associated with Taxotere formulation: a retrospective study in a population of breast cancer patients treated with docetaxel as an adjuvant or neoadjuvant chemotherapy.
Journal: Anti-cancer drugs
Published: August 04, 2015
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Journal: The Lancet. Oncology
Published: April 15, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 28, 2015
Health information technology: use it well, or don't! Findings from the use of a decision support system for breast cancer management.
Journal: AMIA ... Annual Symposium proceedings. AMIA Symposium
Published: January 01, 2014
Last Updated: 09/26/2026